Keystone Financial Planning’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,262
| Closed | -$712K | – | 47 |
|
|
2021
Q4 | $712K | Hold |
5,262
| – | – | 0.24% | 37 |
|
|
2021
Q3 | $568K | Buy |
5,262
+86
| +2% | +$9.83K | 0.21% | 36 |
|
|
2021
Q2 | $583K | Buy |
5,176
+100
| +2% | +$11.3K | 0.21% | 36 |
|
|
2021
Q1 | $549K | Hold |
5,076
| – | – | 0.2% | 34 |
|
|
2020
Q4 | $544K | Hold |
5,076
| – | – | 0.23% | 34 |
|
|
2020
Q3 | $445K | Hold |
5,076
| – | – | 0.22% | 35 |
|
|
2020
Q2 | $498K | Hold |
5,076
| – | – | 0.25% | 39 |
|
|
2020
Q1 | $387K | Hold |
5,076
| – | – | 0.22% | 38 |
|
|
2019
Q4 | $449K | Hold |
5,076
| – | – | 0.2% | 43 |
|
|
2019
Q3 | $384K | Hold |
5,076
| – | – | 0.18% | 45 |
|
|
2019
Q2 | $369K | Hold |
5,076
| – | – | 0.18% | 46 |
|
|
2019
Q1 | $409K | Hold |
5,076
| – | – | 0.2% | 43 |
|
|
2018
Q4 | $468K | Hold |
5,076
| – | – | 0.26% | 42 |
|
|
2018
Q3 | $480K | Hold |
5,076
| – | – | 0.25% | 40 |
|
|
2018
Q2 | $470K | Hold |
5,076
| – | – | 0.26% | 42 |
|
|
2018
Q1 | $480K | Hold |
5,076
| – | – | 0.27% | 43 |
|
|
2017
Q4 | $491K | Hold |
5,076
| – | – | 0.26% | 41 |
|
|
2017
Q3 | $451K | Hold |
5,076
| – | – | 0.26% | 42 |
|
|
2017
Q2 | $368K | Hold |
5,076
| – | – | 0.22% | 44 |
|
|
2017
Q1 | $331K | Hold |
5,076
| – | – | 0.21% | 44 |
|
|
2016
Q4 | $318K | Hold |
5,076
| – | – | 0.21% | 43 |
|
|
2016
Q3 | $320K | Hold |
5,076
| – | – | 0.21% | 41 |
|
|
2016
Q2 | $314K | Hold |
5,076
| – | – | 0.21% | 41 |
|
|
2016
Q1 | $290K | Hold |
5,076
| – | – | 0.21% | 41 |
|
|
2015
Q4 | $301K | Hold |
5,076
| – | – | 0.23% | 41 |
|
|
2015
Q3 | $276K | Hold |
5,076
| – | – | 0.22% | 41 |
|
|
2015
Q2 | $341K | Hold |
5,076
| – | – | 0.26% | 39 |
|
|
2015
Q1 | $297K | Hold |
5,076
| – | – | 0.23% | 39 |
|
|
2014
Q4 | $332K | Sell |
5,076
-227
| -4% | -$14.3K | 0.24% | 41 |
|
|
2014
Q3 | $306K | Sell |
5,303
-20,113
| -79% | -$1.12M | 0.23% | 42 |
|
|
2014
Q2 | $1.43M | Sell |
25,416
-574
| -2% | -$30.1K | 1.08% | 29 |
|
|
2014
Q1 | $1.34M | Sell |
25,990
-18,071
| -41% | -$913K | 1.03% | 28 |
|
|
2013
Q4 | $2.33M | Buy |
+44,061
| New | +$2.17M | 1.86% | 26 |
|
Other funds holding ABBV
Keystone Financial Planning's ABBV Position: Q1 2022 in Review
Keystone Financial Planning sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 5,262 shares — an estimated $712K sold.
Keystone Financial Planning first reported a position in ABBV in Q4 2013 and held it in 33 quarters. The position peaked at $2.33M in Q4 2013. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Keystone Financial Planning reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
- Keystone Financial Planning sold 5,262 AbbVie shares in Q1 2022, an estimated $712K.
- Keystone Financial Planning first reported a position in AbbVie in Q4 2013 and held it in 33 quarters.
- Keystone Financial Planning's AbbVie position peaked at $2.33M in Q4 2013.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Keystone Financial Planning's 13F filing for Q1 2022, filed 28 Apr 2022.